Taken together, we speculate that during HT pathogenesis, inflammatory cytokines induce IL-23 production from TFCs, which functions as an autocrine cytokine and inhibits autophagy activation through AKT/mTOR/NF-κB signaling pathway activation. The gene discussed is AKT1; the disease is hematocrit.